Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Alliant Techsystems Inc. (ATK) Stock Could Underperform for Years

Page 1 of 2

Military contractor Alliant Techsystems Inc. (NYSE:ATK), née Alliant Techsystems, is bulking up its consumer firearms business — and that’s not a good thing for ATK stock.

Over the past half-year, Alliant Techsystems Inc. (NYSE:ATK) has spent $1.2 billion on acquisitions to expand its presence in the consumer firearms (hunting and target shooting) market. And sure, on the one hand, this is understandable, given the limited prospects analysts give ATK for growing its business organically, and indeed, the very real risk that a downturn in military spending will cause the company’s earnings to shrink.

Alliant Techsystems Inc. (NYSE:ATK)

That’s the one hand. But it’s Alliant Techsystems Inc. (NYSE:ATK)’s other hand I’m worried about — the hand that’s throwing away ATK’s shareholders’ hard-earned cash on a series of overpriced acquisitions.

A history of bad decisions
ATK spent $315 million buying Savage Sports and its rifles and shotguns business. It will soon spend $985 million more for Bushnell’s shooting accessories portfolio. This adds up to $1.2 billion, or nearly 40% of ATK’s own market cap — a market cap that has doubled, incidentally, over the past year.

Now, if ATK had played things smart, and used the inflated share price of its stock to pay for its acquisitions of Savage and Bushnell, that wouldn’t have been so bad. Instead, the company paid cash for Savage, and plans to pay cash again to acquire Bushnell.

This is cash, incidentally, that Alliant Techsystems Inc. (NYSE:ATK) does not have. What it does have is debt — nearly $1.3 billion in debt, versus less than $100 million in cash in its bank account. And it’s going to have even more debt on its books after taking out $900 million in senior secured financing to fund the Bushnell buyout.

Take Bushnell for example — the company’s more recent, and bigger mistake. By ATK’s own admission, it will take until 2016 for Bushnell to add $1 to ATK’s earnings per share. Alliant Techsystems Inc. (NYSE:ATK) only has 32 million shares outstanding, so this means management hopes that a company — that ATK is paying $985 million to buy today, let’s not forget — might possibly earn it $32 million two years from now.

That works out to ATK paying 32 times (very) forward earnings for its new prize… at a time when ATK’s own shares cost less than 12 times earnings. Now, granted, Bushnell is a bit more profitable than ATK’s core business. (I calculate a 13% EBITDA margin for ATK, 16.4% for its target). But it’s not three times more profitable — which is what it would take to justify paying three times Alliant Techsystems Inc. (NYSE:ATK)’s own P/E ratio for it.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!